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Abstract. The present study reports the characteristics of the
biochemical profile of human gastric adenocarcinoma in
comparison with that of healthy gastric mucosa, using ex vivo
HR-MAS Magnetic Resonance Spectroscopy. Healthy
human mucosa is mainly characterized by the presence of
small metabolites (more than 50 identified) and macro-
molecules, whereas the adenocarcinoma spectra are
dominated by the presence of signals due to triglycerides,
whose content on the contrary is very low in healthy gastric
mucosa. The use of spin-echo experiments enable us to
detect some metabolites in the unhealthy tissues and to
determine their variation with respect to the healthy ones. We
have observed that the Cho:ChoCC ratio changes from 20:80
in the healthy tissues to 80:20 in the neoplastic gastric
mucosa.
Introduction
Gastric cancer is the leading cause of cancer related death in
many parts of the world (1). Gastric carcinogenesis is a
multistep and multifactorial process that in many cases
involves a progression from normal mucosa through chronic
gastritis, atrophic gastritis and intestinal metaplasia to
dysplasia and carcinoma (2). A number of pre-cancerous
conditions such as atrophic gastritis and intestinal metaplasia
have been recognised due to Helicobacter pylori (H. pylori)
infection or autoimmunity and there are putative associations
with environmental agents such as dietary constituents and
the formation of carcinogenic N-nitroso compounds within
the stomach (3). The detection of early lesions, without lymph
node involvement or distant metastases, would result in a
reduction of mortality (4). Thus, achieving a better
understanding of the molecular features of gastric cancer and
the development of reliable methods for early detection is
highly desirable.
In vivo Magnetic Resonance Spectroscopy (MRS) is a
molecular investigation method well suited to the correlation
of the biochemical composition of human tissues with their
diseases with particular regard to neoplasms (5-7). The
clinical impact of MRS in medicine has been widely
reviewed by Smith and Steward (8) and is currently showing
promise as a method that can complement routine diagnostic
tools such as endoscopy and histopathology. It provides
biochemical information, and it is thus in a position to detect
early, pre-morphological molecular changes in tissue.
Whereas organs, such as the brain, prostate, breast (5-7) have
been widely studied, and MRS is used routinely in clinical
medicine to analyse them, MRS in the evaluation of
neoplasms of human gastric mucosa is in its infancy. In a
previous study (9) we identified the molecular profile
characteristics of the healthy human gastric mucosa. Ex vivo
HR-MAS MRS performed at 9.4 T on gastric specimens
collected during endoscopy, permitted the identification of
more than 40 metabolites giving a detailed picture of the
biochemical pattern of healthy gastric tissues. We hypo-
thesised that the data will be used for a comparison with
gastric pre-neoplastic and neoplastic situations. Moreover,
the full knowledge of the biochemical pattern of these tissues
is necessary for the application of MRS directly in vivo. In
this context, a recent study assessing the clinical usefulness
of ex vivo low resolution MRS in the evaluation of human
gastric carcinomas was performed (10).
As part of a more comprehensive investigation on the
biochemical characterisation of human healthy and
neoplastic tissues through ex vivo HR-MAS MRS analysis
(9,11), we report a study aimed at elucidating the main
metabolic characteristics of human adenocarcinomas in
comparison with healthy gastric mucosa. To our knowledge
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only one report (10) exists on gastric adenocarcinoma
obtained from low resolution ex vivo MR spectrum of the
composite mucosal/submucosal layer and underlines that a
decreased level of lipids together with an increased level of
lactate and choline peaks is a marker for malignancy.
Materials and methods
Selection of the patients. Sixteen patients, 5 with gastric
carcinoma (2 male, mean age 70.6±12.9 years, range 59-86
years) and 11 healthy subjects (7 male, mean age 49.3±17.3
years, range 30-86 years) were evaluated. Of the 16 patients
examined 14 underwent endoscopy, 2 underwent surgery for
gastric adenocarcinoma; in all cases, sample of  healthy
gastric mucosa were collected.
All 5 patients with gastric cancer showed an H. pylori
infection while no healthy subjects presented an H. pylori
infection. Histological appearance was consistent with
adenocarcinoma well differentiated in 3 patients, poorly
differentiated and undifferentiated in one patient, respectively.
The patients gave written informed consent to participate
in the study which was approved by the local research ethics
committee. For each eligible patient, 8 biopsies were taken
(4 biopsies from the antrum and 4 from the gastric body)
during endoscopy. Among them, 4 were used for routine
histological evaluation (H&E) and 4 were put in liquid
nitrogen and stored at -85˚C. Endoscopy was performed
using the Olympus Videoendoscope 140 series and biopsy
forceps (Olympus FB24Q), after sterilization in acetylacetic
acid. The biopsies were obtained, on healthy tissues, in the
subjects who did not present visible macroscopic alterations
and the tissues were considered healthy only if the histo-
logical examination confirmed the macroscopic finding. The
tissues were obtained from the mucosa and submucosal layer.
In the patients with gastric cancer the biopsies were obtained
from the lesion in the clearly macroscopic aspect of
carcinoma and in normal appearing mucosa far from lesion.
The gastric biopsies were fixed in neutral buffered formalin,
routinely processed and stained with Giemsa and H&E. The
Goseki classification (12) was used for grading adeno-
carcinoma.
Tissue samples. The tissue samples were quickly frozen in
liquid nitrogen after surgery to avoid microcrystallization of
the water in the cell, causing damage and stored at -85˚C,
until MRS analysis. Before MRS analysis all samples were
washed with D2O, in order to eliminate the blood, prior to the
insertion into the zirconia MAS rotor (4 mm OD). Sample
and instrument preparation took ~20 min. Regarding sample
2, 9 pieces were selected in different places of the tissue, but
the MR spectra did not show any significant differences.
Magnetic Resonance Spectroscopy. Proton HR-MAS MR
spectra were recorded with a Bruker Avance400 spectro-
meter equipped with a 1H/13C HR-MAS probe operating at
400.13 and 100.61 MHz, respectively. Samples were spun at
4000 Hz and three different types of 1D proton spectra were
acquired by using i) a composite pulse sequence (13) with a
1.5 sec water-presaturation during relaxation delay, 8 kHz
spectral width, 32 k data points, 32 scans, ii) a water-
suppressed spin-echo Carr-Purcell-Meiboom-Gill (CPMG)
sequence (14) with a 1.5 sec water presaturation during
relaxation delay, 1 msec echo time (τ) and 360 msec total
spin-spin relaxation delay (2nτ), 8 kHz spectral width, 32 k
data points, 256 scans and iii) a sequence for diffusion
measurements based on stimulated echo and bipolar-gradient
pulses (15) with big delta 200 msec, eddy current delay Te 5 ms,
little delta 2*2 msec, sine-shaped gradient with 32 G/cm
followed by a 200 μsec delay for gradient recovery, 8 kHz
spectral width, 8 k data points, 256 scans. Two-dimensional
(2D) 1H,1H-Correlation Spectroscopy (COSY) (16,17)
spectra were acquired using a standard pulse sequence and a
0.5 sec water-presaturation during relaxation delay, 8 kHz
spectral width, 4 k data points, 32 scans per increment, 256
increments. 2D 1H,1H-TOtal Correlation Spectroscopy
(TOCSY) (18,19) spectra were acquired using a standard
pulse sequence and a 1 sec water-presaturation during
relaxation delay, 100 msec mixing (spin-lock) time, 4 kHz
spectral width, 4 k data points, 32 scans per increment, 128
increments. 2D 1H,13C-Heteronuclear Single Quantum
Coherence (HSQC) (20,21) spectra were acquired using a
standard pulse sequence with echo-antiecho phase sensitive
and 0.5 sec relaxation delay, 1.725 msec evolution time, 4 kHz
spectral width in f2, 4 k data points, 128 scans per increment,
17 kHz spectral width in f1, 256 increments.
Results and Discussion
Conventional presaturated 1D spectra, representative of the
healthy (trace a) and neoplastic (trace b) gastric mucosa are
reported in Fig. 1. The healthy mucosa shows the presence
of the resonances deriving from low molecular weight
metabolites and macromolecules, whereas the adeno-
carcinoma is characterized by the presence of predominant
signals due to triglycerides, whose content is very low in a
healthy stomach. The MR spectra performed on 11 samples
of healthy gastric mucosa confirm the metabolic profile
detected in a previous study (9).
The complete characterisation of healthy mucosa was
performed acquiring spin-echo sequence [90˚ - (τ-180˚-τ)n],
choosing τ and n in order to separate the signals according to
their different T2 values allowing us to show the contribution
due to mobile small molecules.
The full assignment of metabolites of the healthy tissues
was performed, as already reported (9) through selected 2D
experiments such as COSY, TOCSY and HSQC. The COSY
and the TOCSY spectra are very informative for the
identification of hidden resonances. The COSY spectra
enable the coupled proton-proton pairs to be found, whereas
the TOCSY spectra permit the identification of 1H-1H
connectivities up to five or six bonds. 1H,13C HSQC spectra
were performed in order to identify the correlations between
directly bonded carbon-proton pairs thus making possible the
assignment of the singlets (which do not give correlations in
homonuclear COSY and TOCSY spectra) by comparison of
both 1H and 13C data with those of other reports, and to
distinguish signals from different molecules having similar
proton chemical shifts but diverse 13C signals. These
experiments permit the complete and unambiguous
identification of more than 50 metabolites (Table I) in
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healthy human tissues and to show metabolic changes in
neoplastic human gastric mucosae.
As already observed, the 1H MR spectra of gastric
adenocarcinomas are dominated by the signals due to
triglycerides. At first, we examined the types of fatty acids
with the aim of characterising the relative content of
saturated and unsaturated fatty acids.
Lipids. The proton spectrum of a neoplastic gastric mucosa,
reported in Fig. 2, shows the resonance characteristics of
triglycerides, confirmed by the presence of signals due to
glycerol (5.26, 4.30 and 4.10 ppm) and to long fatty acid
chains. All the examined adenocarcinomas (5 patients, for
patient 2, nine spectra were obtained from sampling in a
different zone of the lesion tissues) showed a virtually
identical spectral profile.
Signals at 2.02 ppm are assigned to methylene protons of
the CH2-CH=CH moiety of mono- and poly-unsaturated fatty
acids, whereas those at 2.78 ppm are attributable to the
methylene protons between two double bonds (=C-CH2-C=)
in poly-unsaturated acids. Furthermore, the unsaturated acids
are identified by the signals at 5.33 ppm due to the protons of
the -CH=CH- moiety.
The ·-linolenic acid is identified by the signal of the
methyl protons at 0.96 ppm and by its correlation with the
methylene protons of the CH2-CH=CH moiety at 2.06 ppm,
detected in the COSY spectrum (Fig. 3).
The presence of linoleic acid is confirmed by the
correlation between the triplet at 2.78 ppm (=C-CH2-C=) and
the signal at 2.02 ppm (CH2-CH=CH) and by that with the
signal at 5.33 ppm (CH=CH).
The analysis of the fat components, in the percentage of
saturated, mono- and poly-unsaturated was performed
through the integration of suitable signals: the starting point
is represented by the integrated area of the CH2(·) to C=O at
2.24 ppm. The percentage of unsaturated acids was evaluated
by the ratio between the experimental and theoretical values
of the integrated area of CH2(·) to double bond. The
integrated area of CH2(·) to the double bond, due to mono-
and poly-unsaturated acids was corrected by the contribution
of CH2(·) of linoleic and ·-linolenic acids, which is derived
by the integrated area of the signal at 2.78 ppm, establishing
that the ratio of mono- and poly-unsaturated components is
ca.3:1, in all the examined samples. The ·-linolenic
percentage was derived by the area of the terminal methyl
signal at 0.96 ppm. The composition of triglycerides is
reported in Table II.
Limited assessment can be made on the 13C MR spectra
obtained with HR-MAS technique. A carbon spectrum
representative of all the samples analysed is displayed in
Fig. 4.
The spectrum is of good quality, with a resolution
comparable to that obtained in solution, permitting the
evaluation of the composition of triglycerides. Three signals
are present in the carbonyl region, at 172.26, 172.24 and at
171.97 ppm. The more deshielded signals are due to the
carbonyls in the 1,3 positions (sn1,3) and the other to the
carbonyl in the 2 position (sn2) of glycerol. The slight
difference of the carbonyl resonances in sn1,3 suggests that
the triglycerides are mixed, even if no difference is observed
in the sn2 carbonyl resonance. The two groups of signals
centered at 130.1 and 128.5 ppm are due to olefinic carbons:
In particular the latter are attributable to the internal carbons
of the double bonds in linoleic and ·-linolenic acid, whereas
the former are due to the carbons of mono-unsaturated acids
and to external carbons of double bonds in linoleic and ·-
linolenic acid.
The identification of saturated fatty acids is obtained by
the resonances of the CH2CH3 moiety at 23.2 and 14.60 ppm,
whereas that of mono-unsaturated and poly-unsaturated acids
is deducible from the resonances of CH2-CH=CH at 27.8
ppm, CH2CH3 at 23.3 ppm and 14.56 ppm. The linoleic acid
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Figure 1. HR-MAS proton MR spectra of healthy (a) and neoplastic (b) samples.
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Table I. List of 1H and 13C chemical shift (‰, ppm) of metabolites and exogenous molecules found in HR-MAS spectra of
healthy and neoplastic tissuea.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Entry Metabolite ‰ 1H ‰ 13C Neoplasticb
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
1 Fatty acids 0.89 14.13-14.17 CH3 y
1.31 29.4-32.2 (CH2)n
1.59-1.60 25.2 CH2-C-C=O
2.02 27.8 CH2-C=
2.24 34.2 CH2C=O
2.78 26.2 =C-CH2-C=
5.30-5.32 130.2; 128.4 CH=CH
2 Isoleucine 0.94 (t) 11.7 ‰-CH3 trace
1.02 (d) 15.5 Á-CH3
1.29,1.48 25.1 Á-CH2
1.97 ß-CH
3.69 ·-CH
3 Leucine 0.95 (d) 21.5 ‰-CH3 trace
0.97(d) 22.8 ‰-CH3
1.70 40.4 Á-CH
1.72 ß-CH2
3.74 ·-CH
4 Valine 0.99 (d) 17.3 Á-CH3 y
1.04 (d) 18.7 Á-CH3
2.25 ß-CH
3.61 d ·-CH
5 Threonine 1.33 (d) 20.3 Á-CH3
4.26 66.58 ß-CH trace
3.60 61.22 ·-CH
6 Lactate 1.33 (d) 20.3 CH3 y
4.11 69.1 CH
7 Lidocaine 1.37 (t) 9.2 CH3
chlorohydrate 3.37 (q) 50.6 CH2
2.20 (s) 17.8 2,6-CH3
8 ß-Alanine 2.56 32.14 CH2
3.18 40.01 CH2
9 Alanine 1.48 (d) 16.8 ß-CH3 y
3.78 51.1 ·-CH
10 Lysine 3.02 (t) 39.9 ε-CH2 y
1.71 27.1 ‰-CH2
1.48 22.56 Á-CH2
1.91 30.6 ß-CH2
3.79 c ·-CH
11 Arginine 3.23 41.3 ‰-CH2
1.69 Á-CH2
1.92 28.1 ß-CH2
3.78 c ·-CH
12 Glutamate 2.36 (t) 34.0 Á-CH2 y
2.06, 2.14 27.9 ß-CH2
3.77 c ·-CH
13 Glutamine 2.44 (td) 31.5 Á-CH2 trace
2.14 27.2 ß-CH2
3.78 c ·-CH
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Table I. Continued.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Entry Metabolite ‰ 1H ‰ 13C Neoplasticb
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
14 Proline 3.43, 3.34 ‰-CH2
2.01 Á-CH2
2.34, 2.07 ß-CH2
4.12 ·-CH
15 Methionine 2.13 (s) 14.9 SCH3 y
2.62 Á-CH2
2.16 ß-CH2
3.87 ·-CH
16 Aspartic acid 2.68, 2.82 37.2 ß-CH2
3.90 ·-CH
17 Asparagine 2.85, 2.96 26.30 ß-CH2
4.01 ·-CH
18 Creatine 3.04 (s) 37.5 NCH3 y
3.92 (s) 54.5 CH2
19 Tyrosine 3.06, 3.20 ß-CH2 y
3.93 56.7 ·-CH
6.89 116.5 Hortho
7.23 131.5 Hmeta
20 Phenylalanine 3.11, 3.28 ß-CH2 y
3.99 ·-CH
7.34 130.1 Hortho
7.44 129.6 Hmeta
7.37 Hpara
21 Ethanolamine 3.15 (t) CH2 trace
3.82 (t) CH2
22 Phosphory- 3.23 41.1 CH2 y
lethanolamine 4.07 61.1 CH2
23 Glycerophosphory- 3.30 CH2
lethanolamine 4.10 CH2
24 Free choline 3.20 54.6 N(CH3)3 y
3.53 68.2 NCH2
4.08 56.5 OCH2
25 Glycerophosphoryl- 3.22 54.7 N(CH3)3
choline 3.68 NCH2
4.33 OCH2
26 Phosphorylcholine 3.22 54.7 N(CH3)3 y
3.61 67.3 NCH2
4.22 59.0 OCH2
27 ß-Glucose 4.67 (d) 96.6 1-CH y
3.26 74.8 2-CH
3.49 76.8 3-CH
3.40 69.9 4-CH
3.47 76.8 5-CH
e e 6-CH2
28 Taurine 3.26 (t) 48.1 SCH2 y
3.42 (t) 35.9 NCH2
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Table I. Continued.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Entry Metabolite ‰ 1H ‰ 13C Neoplasticb
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
29 Myoinositol 3.53 (dd) 71.8 1,3-CH y
4.06 (t) 72.9 2-CH
3.63 (t) 73.1 4,6-CH
3.30 (t) 75 5-CH
30 Scylloinositol 3.35 (s) 54.6 CH y
31 ·-Glucose 5.24 (d) 1-CH y
3.54 72.0 2-CH
3.73 3-CH
3.42 70 4-CH
e e 6-CH2
32 Glycine 3.56 42.3 CH2 y
33 PEG 3.72 69.9 trace
34 Glycerol 4.10, 4.30 62.3 1,3-CH2 y
(in lipids) 5.26 69.8 2-CH
35 Glycerol 3.56, 3.65 63.3 1-CH2
3.81 72.7 2-CH
36 Bonded 3.95-3.70 61.3 1,3-CH2
glycerols
37 UDP 5.92 1-CHrib
4.35 2-CHrib
5.90 (d) 5-CHur
7.89 (d) 6-CHur
38 Uracil 5.80 (d) 5-CHur
7.54 (d) 6-CHur
39 UMP 5.98 1-CHrib
4.37 2-CHrib
5.97 (d) 5-CHur
8.11 (d) 6-CHur
40 Formiate 8.48 CH
41 Adenosine 8.36 (s) 2-CH y
8.23 (s) 8-CH
42 Acetate 1.92 24.8 CH3C=O y
43 Hypotaurine 2.65 (t) 38.73 CH2 trace
3.35 (t) 41.19 CH2
44 Tryptophane 7.73
7.19
7.29
7.52
45 ·Glc-1-X 5.40 100.2
3.61
46 Glutathione 4.57 56.18 Á-CH2-Cys
2.96 26.3 ß-CH2-Cys
3.80 ·-CH-Glu
2.16 ß-CH2-Glu
2.55 Á-CH-Glu
3.77 44 Gly
8.57 NH-Cys
8.36 NH-Gly
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is clearly identified by the resonance of =C-CH2-C= at 26.1
ppm. The 13C resonance of the ·-linolenic acid was not
detected due to its low level.
The MRS data of lipids obtained through the MR analysis
is reported in Table III.
Triglyceride
—CH2CH2CH2CH2(CH2)nCH2CH2CH2CH2 Saturated acids
—CH2CH2CH2(CH2)3CH2CH=CHCH2(CH2)n=CH2CH2CH2CH3
χ      ψ
Mono-unsaturated acids (M)
—CH2CH2CH2(CH2)3CH2CH=CHCH2CH2CH2CH2CH3 Linoleic acid (L)
· ‚     Á
—CH2CH2CH2(CH2)3CH2CH=CH-CH2-CH2=CHCH2CH3 ·-Linolenic acid (·-L)
Scheme 1. Triglycerides and relative numbering.
The assignment of 13C MR signals of the triglycerides
was made through the 1H,13C HSQC experiment and by
comparison with literature data (22). The detection of lipids
in all the gastric adenocarcinomas examined differentiates
them from healthy mucosa in which their amounts are very
low. This finding is in opposition with that of Mun et al (10)
who reported a decreased level of lipids in gastric adeno-
carcinomas detected from low resolution ex vivo MR
spectrum of the composite mucosal/submucosal layer.
Research on the lipidic component of cells and tissues
recognised them as having a fundamental role in cell life and
death (23), and analytical studies performed by spectroscopic
techniques have gained importance. Indeed, deposits of
neutral lipids in human cells and tissues have been revealed
and identified by MRS. Some authors have speculated that
1H resonances, attributed to mobile lipids, originate from
lipid droplets made of triglycerides and cholesteryl esters
located both in the cytoplasm (24,25) and in the plasma
membrane (26). The importance of these 1H visible lipids in
the life and death of cells has been highlighted by Hakumaki
and Kauppinen (23) and the direct relationship between
Nuclear Magnetic Resonance-visible lipids, lipid droplets
and cell proliferation has been demonstrated by Barba et al
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Table I. Continued.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Entry Metabolite ‰ 1H ‰ 13C Neoplasticb
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
47 ß-OH-butyrate 1.18 CH3 y
4.14
48 Succinate 2.41 (s) ·,ß-CH2 y
49 Histidine 7.78 (s) 2-CH y
7.05 (s) 4-CH
50 Ascorbate 4.52 (d) 4-CH
4.01 5-CH
51 Unknown 1.63 23.5
52 Unknown 2.44
3.44
53 Bonded Thr 1.22 16.2 Á-CH3
4.24 ß-CH
4.31 ·-CH
54 Bonded Ala 1.41 17.1 ß-CH3
4.32 ·-CH
55 Bonded Val 0.93 23 Á-CH3
2.08 ß-CH
4.11 ·-CH
56 Cetylpyridinium 5.08 NCH2
2.03 ß-CH2
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
a1H chemical shift refers to the alanine doublet at 1.48 ppm. 13C chemical shifts refer to alanine at 16.8 ppm; ball metabolites and exogenous
molecules were found in healthy gastric mucosa. In this column are also shown those found in the neoplastic tissues; c, C· contributes to the
3.77, 55.1 ppm cross-peak; d, C· contributes to the 3.61, 61.1 ppm cross-peak; e, contributes to the broad correlation between CH2 protons
in the region 3.9÷3.6 ppm and carbons around 62 ppm in the HSQC spectra.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
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(27). Moreover, a positive correlation between the presence
of lipid droplets detected in vivo by MRS and necrosis in rat
brain glioma has been reported (28). All of this evidence
shows how these lipid droplets, formed mainly by trigly-
cerides, are closely involved in the various aspects of tumor
cell transformation.
In agreement with the above findings, we have detected
many triglycerides in all the examined adenocarcinomas
collected by endoscopy or surgery. High amounts of lipids in
clear cell renal carcinoma samples were detected, by ex vivo
HR-MAS MRS, by Tate et al (29). Our results therefore are
not surprising even if ultra-structural further investigations
are needed to better elucidate the localization of these
compounds and to understand their role and significance in
gastric adenocarcinomas.
Low molecular-weight metabolites in gastric adeno-
carcinoma. The CPMG experiment permits the attenuation of
the signal due to lipids and to show the signals arising from
small metabolites in the neoplastic tissue; in this type of
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Figure 2. 1H HR-MAS MR spectrum of cancerous gastric mucosa.
Figure 3. COSY spectrum of sample 2. The correlation CH2-CH3 of ·-linolenic acid is shown.
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sample a good CPMG spectrum, i.e. a good suppression of
lipid resonances, can be obtained using a total spin-echo time
of 720 msec. The corresponding spectrum is reported in
Fig. 5.
Some metabolites can be identified by the comparison
with the corresponding healthy tissues. In particular,
adenosine, alanine (Ala), phenylalanine (Phe), tyrosine (Tyr),
histidine (His), ß-glucose (ß-Glc), ·-glucose (·-Glc),
phosphorylcholine (PC, trace), myoinositol (Myo),
phosphorylethanolamine (PE), glycine (Gly), taurine (Tau),
hipotaurine (HTau), scyllo-inositol (Scy), choline containing
compounds (ChoCC), free choline (Cho), ethanolamine (E),
succinate (Suc), glutamine (Gln), glutamate (Glu), methionine
(Met), acetate (Ac), hydroxibutyrate (OH-But), valine (Val)
and low amounts of isoleucine (Ile) and leucine (Leu), are
recognizable. Polyethylen glicole (PEG) was present in small
amounts in only some samples.
Different relative ratios of metabolites were found in the
healthy and neoplastic tissues as is clearly evident in the two
spectra reported in Fig. 6.
At a glance, the major differences are found in the
increased amount of Gly in neoplastic tissues with respect to
the healthy ones. It has been suggested that the inter-
mediates of a more bioactive glycolitic pathway in
neoplasms are responsible for the increase in Gly amounts,
involving phosphoglycerate and serine (30). In agreement
with these findings, several authors reported Gly as the most
notable peculiarity in glioblastomas (31,32) and breast
tumors (29). Moreover, in the case of breast tumors, high
amount of Gly were correlated to tumor size, cellularity and
the presence of positive lymph node (33).
Another difference, recurrent in all the examined adeno-
carcinomas, besides the change in the ChoCC:Cr ratio which
passes from 16:1 in all the healthy samples to 2.5:1 in the
neoplastic ones, is found in the relative abundance of Cho
with respect to ChoCC. Healthy gastric mucosa is
characterised by high amount of PC and low amounts of Cho
and GPC, with a mean Cho:ChoCC ratio of 1:5. Instead, the
adenocarcinoma samples were characterised by large
amounts of Cho and very low amounts of PC and GPC with a
mean ratio Cho:ChoCC of 4:1.
PEG is a component of the anesthetic formulation
administered to patients before endoscopy, and its presence
was detected, through the strong singlet at 3.72 ppm only in
healthy gastric mucosa; whereas it is absent or only in traces
in all the gastric adenocarcinoma samples. It is interesting to
note that this molecule is preferentially fixed in the healthy
tissues only.
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Figure 4. The 13C spectrum of patient 2 biopsy.
Table II. Percentage of different fatty acid components in the
adenocarcinoma samples.
–––––––––––––––––––––––––––––––––––––––––––––––––
Unsaturated
––––––––––––––––––––––––––––––––––
Patients Saturated Mono- Poly-
unsaturated unsaturated
–––––––––––––––––––
Linoleic ·-Linolenic
–––––––––––––––––––––––––––––––––––––––––––––––––
1 20% 64% 14% 2%
2 28% 56% 13% 3%
3 23% 65% 10% 2%
4 26% 48% 24% 2%
5 28% 46% 24% 2%
–––––––––––––––––––––––––––––––––––––––––––––––––
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Table III. NMR data (1H,13C) of fatty acids in neoplastic gastric mucosa.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
C=O CH2(·) CH2(ß) (CH2)n CH2CH=CH CH=CH =C-CH2-C= CH2(¯) CH2(ψ) CH3
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
C 172.26 34.2, 25.5 29.7÷30.6 27.8 (M+L) 130.1, 26.1 (L) 32.65, 23.3 (M+L), 14.60 (M+L),
172.24 34.3 128.5 32.51, 23.2 (S) 14.56 (S)
171.97 32.18 (S)
–––––––––––––––––––––––
H 2.24 - 1.60 2.02, 5.33 2.78 (L), 1.28÷1.32 0.89,
2.06 (·-L) 2.81(·-L) 0.96 (·-L)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
For numbering see Scheme 1.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Figure 5. The CPMG spectrum of gastric adenocarcinoma tissue.
Figure 6. The CPMG spectra of healthy gastric mucosa (trace a) and adenocarcinoma (trace b).
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In conclusion, this report represents the first study
performed through HR-MAS MRS on ex vivo specimens of
human gastric adenocarcinomas. We characterised the
molecular pattern of neoplastic mucosa and compared it with
that of healthy gastric tissue.
The knowledge of the metabolic profile of healthy and
gastric tumoral tissues could be the basis for the application
of the in vivo MR spectroscopy for diagnostic purposes.
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